Tirzepatide Inj recalls
The FDA has published 2 recalls involving Tirzepatide Inj since 2026. The latest was reported on 11 Mar 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2026
Last 12 months2reported
Class I00% of total
Ongoing2latest 11 Mar 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why tirzepatide inj is recalled
Companies
By year
Ongoing tirzepatide inj recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
| Drug | CLASS II | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
All tirzepatide inj recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
| Drug | CLASS II | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
Should you stop taking Tirzepatide Inj?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.